HDAC6 plays a non-canonical role in the regulation of anti-tumor immune responses, dissemination, and invasiveness of breast cancer.

Despite the outstanding clinical results of immune checkpoint blockade (ICB) in melanoma and other cancers, clinical trials in breast cancer have reported low responses to these therapies. Current efforts are now focused on improving the treatment efficacy of ICB in breast cancer using new combinati...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Res
Main Authors: Banik, Debarati, Noonepalle, Satish, Hadley, Melissa, Palmer, Erica, Gracia-Hernandez, Maria, Zevallos-Delgado, Christian, Manhas, Namratta, Simonyan, Hayk, Young, Colin N., Popratiloff, Anastas, Chiappinelli, Katherine B., Fernandes, Rohan, Sotomayor, Eduardo M., Villagra, Alejandro
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7484424/
https://ncbi.nlm.nih.gov/pubmed/32605998
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-19-3738
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados